RECRUITING

Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction

Description

The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

Conditions

Biliary Obstruction
Talk to us

Related Conditions:

Biliary Obstruction

Study Overview

On this page

Study Details

Study overview

The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

A Comparative Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage of Benign and Malignant Biliary Obstruction

Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction

Condition
Biliary Obstruction
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with benign biliary obstruction
  • * Patients with malignant biliary obstruction
  • * Patients undergoing ERCP and/or PTBD
  • * Patients with gallstone disease
  • * Patients who will undergo ERCP who have previously underwent a PTBD
  • * Patients who will undergo PTBD who have previously underwent an ERCP
  • * Female patients who are pregnant
  • * Prisoners and other vulnerable populations

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Andrew Storm, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2024-12